Silverlake Wealth Management’s Eli Lilly LLY Stock Holding History

Silverlake Wealth Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.71M	Sell	1,861 -175	-9%	-$177K	0.36%	87
2025 Q4	$2.19M	Buy	2,036 +2	+0.1%	+$1.91K	0.49%	55
2025 Q3	$1.55M	Sell	2,034 -3	-0.1%	-$2.23K	0.38%	87
2025 Q2	$1.59M	Buy	2,037 +937	+85%	+$728K	0.46%	70
2025 Q1	$908K	Sell	1,100 -29	-3%	-$24.1K	0.34%	78
2024 Q4	$871K	Hold	1,129	–	–	0.33%	81
2024 Q3	$1,000K	Sell	1,129 -69	-6%	-$62K	0.38%	69
2024 Q2	$1.09M	Sell	1,198 -6	-0.5%	-$4.8K	0.45%	61
2024 Q1	$937K	Sell	1,204 -7	-0.6%	-$4.98K	0.48%	53
2023 Q4	$706K	Buy	1,211 +7	+0.6%	+$4.09K	0.39%	64
2023 Q3	$647K	Sell	1,204 -40	-3%	-$20.6K	0.36%	73
2023 Q2	$583K	Sell	1,244 -54	-4%	-$22.6K	0.32%	75
2023 Q1	$446K	Sell	1,298 -4	-0.3%	-$1.35K	0.27%	94
2022 Q4	$476K	Hold	1,302	–	–	0.3%	80
2022 Q3	$421K	Sell	1,302 -2	-0.2%	-$634	0.29%	89
2022 Q2	$423K	Buy	1,304 +1	+0.1%	+$300	0.28%	94
2022 Q1	$373K	Hold	1,303	–	–	0.21%	132
2021 Q4	$360K	Buy	+1,303	New	+$330K	0.19%	130

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Silverlake Wealth Management's LLY Position: Q1 2026 in Review

Silverlake Wealth Management reduced its Eli Lilly (LLY) stake by 8.6% in Q1 2026, selling an estimated $177K and leaving 1,861 shares worth $1.71M. The position accounts for 0.36% of the portfolio, ranked #87.

Silverlake Wealth Management first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.19M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Silverlake Wealth Management held 1,861 shares of Eli Lilly worth $1.71M as of Q1 2026.
Silverlake Wealth Management sold 175 Eli Lilly shares in Q1 2026, an estimated $177K.
Eli Lilly made up 0.36% of Silverlake Wealth Management's portfolio in Q1 2026, its #87 holding.
Silverlake Wealth Management first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
Silverlake Wealth Management's Eli Lilly position peaked at $2.19M in Q4 2025.
4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Silverlake Wealth Management's 13F filing for Q1 2026, filed 15 Apr 2026.